Why the study?
Serum renin concentration is markedly elevated in catecholamine-resistant vasodilatory shock and may identify patients who benefit from angiotensin II treatment.
Does angiotensin II improve survival in patients with catecholamine-resistant vasodilatory shock?
Does angiotensin II improve survival in patients with catecholamine-resistant vasodilatory shock?
Elevated serum renin concentration may identify patients with catecholamine-resistant vasodilatory shock who have a beneficial clinical response to angiotensin II.
May support renin testing to select angiotensin II responders in shock; leaves open survival benefit in prospective trials.
The serum renin concentration is markedly elevated in CRVS and may identify patients for whom treatment with angiotensin II has a beneficial effect on clinical outcomes.Clinical trial registered with www.clinicaltrials.gov (NCT02338843).
No takes yet. Share an insight, caveat, or question.
Bellomo et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: